Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-18

Clinical Trial Update: Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing the efficacy of ACE inhibitors, MRAs, and a combination therapy in diabetic nephropathy with microalbuminuria due to typ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACE inhibitor/MRA combination
  • ACE inhibitors
  • MRAs

Snippet

Sponsor: Beni-Suef University | Conditions: Diabetic Nephropathy Type 2, Microalbuminuria Due to Type 2 Diabetes Mellitus | Phase 2 | Status: UNKNOWN